Log in or Sign up for Free to view tailored content for your specialty!
Rheumatoid Arthritis News
VIDEO: Patients on biologics for rheumatoid arthritis had higher rates of Staphylococcus aureus
PHILADELPHIA — At the Musculoskeletal Infection Society Annual Open Scientific Meeting, Andy O. Miller, MD, infectious disease specialist at Hospital for Special Surgery, said patients with rheumatoid arthritis who were on biologics had higher rates of Staphylococcus aureus skin carriage.
GDP, drug affordability impact nations' RA disease activity, biological DMARD use
Disease activity and the use of biological disease-modifying antirheumatic drugs among patients with rheumatoid arthritis vary from country to country, with many factors influencing their inverse relationship, including per capita gross domestic product, drug affordability and reimbursement rules, according to findings published in the Annals of the Rheumatic Diseases.
Log in or Sign up for Free to view tailored content for your specialty!
Lower vitamin D level linked to higher RA disease severity
Vitamin D deficiency is associated with increased disease severity among patients with rheumatoid arthritis, according to findings presented at the AACC Annual Scientific Meeting & Clinical Lab Expo, in Chicago.
Women with obesity, higher body fat at greater risk for RA
Obesity, higher body fat and higher waist circumference are associated with a greater risk for rheumatoid arthritis among women, according to findings published in Arthritis Care & Research.
Primary care consultation rates higher in 2 years prior to RA diagnosis
Patients who eventually develop rheumatoid arthritis have higher rates of primary care consultation at least 2 years prior to their physician’s first recorded suspicion that they may have the disease, according to findings published in Seminars in Arthritis and Rheumatism.
Genetic biomarker linked to RA disease severity may guide targeted therapies
The gene HIP1 has been newly associated with rheumatoid arthritis disease severity, and could potentially prove to be a novel predictive biomarker and target for treatment, according to findings published in the Annals of the Rheumatic Diseases.
Mobile apps for patients with RA lack educational, symptom management features
Most mobile apps currently available on iTunes and the Google Play store that are aimed at patients with rheumatoid arthritis fail to provide users with a comprehensive experience, with few providing both educational information and the ability to track symptoms, according to findings published in the Journal of Clinical Rheumatology.
EULAR recommends physical activity as part of standard care for inflammatory arthritis, OA
Physical activity should be an integral part of standard care in the treatment of inflammatory arthritis and knee and hip osteoarthritis, and all health care providers should take responsibility for promoting its use, according to recommendations released by EULAR.
Nearly half of female hydroxychloroquine users in UK excess-dosed
Approximately 47% of female patients in the United Kingdom who are prescribed hydroxychloroquine are given excess doses, based on ideal-body-weight dosing, according to findings published in Arthritis Research & Therapy.
Only 30% of RA patients report dietary supplement use to physicians
Although nearly half of patients with RA use natural dietary supplements, just 30% of these patients inform their physician about their use, according to findings published in Arthritis Care & Research.
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read
-
Headline News
First US case of clade I mpox reported in California
November 18, 20242 min read -
Headline News
'On the frontlines of public health': Physicians leverage trust against firearm violence
November 19, 20246 min read -
Headline News
Data support early, continued lecanemab dosing for Alzheimer’s
November 19, 20242 min read